Interpreting serological tests in diagnosing autoimmune liver diseases

Pietro Invernizzi, Ana Lleo, Mauro Podda

Research output: Contribution to journalArticle

83 Scopus citations

Abstract

Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should he a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.

Original languageEnglish (US)
Pages (from-to)161-172
Number of pages12
JournalSeminars in Liver Disease
Volume27
Issue number2
DOIs
StatePublished - May 2007
Externally publishedYes

    Fingerprint

Keywords

  • Autoimmune hepatitis
  • Overlap syndromes
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Serum autoantibodies

ASJC Scopus subject areas

  • Hepatology

Cite this